These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 4398745

  • 1. Reflex and other cardiovascular changes in anesthetized dogs after beta adrenergic blockade.
    Robson RD, Lewis D, Thompson S.
    J Pharmacol Exp Ther; 1971 Mar; 176(3):662-71. PubMed ID: 4398745
    [No Abstract] [Full Text] [Related]

  • 2. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T, Kubota M, Tamura A, Suzuki K, Furukawa Y.
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract] [Full Text] [Related]

  • 3. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y.
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological aspects of oxprenolol.
    Brunner H, Hedwall PR, Maier R, Meier M.
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT, Gluckman MI.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract] [Full Text] [Related]

  • 7. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T, Takano M, Tamura A, Kubota H, Suzuki N.
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E, Kucharczyk M, Holtz J, Stoian D.
    Pflugers Arch; 1972 May; 332(1):40-55. PubMed ID: 4401667
    [No Abstract] [Full Text] [Related]

  • 10. Effects of beta-adrenoreceptor blockade and nitroglycerin on myocardial oxygenation.
    Winbury MM, Weiss HR, Howe BB.
    Eur J Pharmacol; 1971 May; 16(3):271-7. PubMed ID: 4399875
    [No Abstract] [Full Text] [Related]

  • 11. Proceedings: The effects of beta-adrenergic blockade upon the cardiovascular responses of the rat to noradrenaline infusions.
    Imms FJ, Neame RL, Powis DA.
    J Physiol; 1974 Aug; 241(1):47P-49P. PubMed ID: 4153711
    [No Abstract] [Full Text] [Related]

  • 12. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L.
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
    Tavares P, Viana AR, Ximenes-Neto M, Martinelli JG.
    Rev Bras Anestesiol; 1971 Jun; 21(4):596-601. PubMed ID: 4401689
    [No Abstract] [Full Text] [Related]

  • 17. Effect of adrenergic blockade on cardiovascular responses to increased airway pressure.
    Feisal KA, Abboud FM, Eckstein JW.
    Am J Physiol; 1967 Jul; 213(1):127-33. PubMed ID: 6027908
    [No Abstract] [Full Text] [Related]

  • 18. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
    Singh N, Srivastava RK, Kulshrestha VK, Sinha JN, Kohli RP, Bhargava KP.
    Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
    [No Abstract] [Full Text] [Related]

  • 19. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD, Kappagoda CT, Linden RJ, Snow HM.
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M, Imamura H, Nakamura T, Kimura T.
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.